1. Home
  2. AMRX vs AVNT Comparison

AMRX vs AVNT Comparison

Compare AMRX & AVNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • AVNT
  • Stock Information
  • Founded
  • AMRX 2002
  • AVNT 1927
  • Country
  • AMRX United States
  • AVNT United States
  • Employees
  • AMRX N/A
  • AVNT N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • AVNT Major Chemicals
  • Sector
  • AMRX Health Care
  • AVNT Industrials
  • Exchange
  • AMRX Nasdaq
  • AVNT Nasdaq
  • Market Cap
  • AMRX 3.3B
  • AVNT 2.9B
  • IPO Year
  • AMRX N/A
  • AVNT 1993
  • Fundamental
  • Price
  • AMRX $11.62
  • AVNT $29.22
  • Analyst Decision
  • AMRX Buy
  • AVNT Buy
  • Analyst Count
  • AMRX 3
  • AVNT 6
  • Target Price
  • AMRX $12.67
  • AVNT $45.67
  • AVG Volume (30 Days)
  • AMRX 1.8M
  • AVNT 663.5K
  • Earning Date
  • AMRX 10-30-2025
  • AVNT 11-05-2025
  • Dividend Yield
  • AMRX N/A
  • AVNT 3.69%
  • EPS Growth
  • AMRX N/A
  • AVNT N/A
  • EPS
  • AMRX 0.02
  • AVNT 1.23
  • Revenue
  • AMRX $2,934,959,000.00
  • AVNT $3,246,100,000.00
  • Revenue This Year
  • AMRX $10.20
  • AVNT $3.23
  • Revenue Next Year
  • AMRX $6.95
  • AVNT $3.20
  • P/E Ratio
  • AMRX $620.20
  • AVNT $23.80
  • Revenue Growth
  • AMRX 9.50
  • AVNT 1.03
  • 52 Week Low
  • AMRX $6.69
  • AVNT $27.86
  • 52 Week High
  • AMRX $12.12
  • AVNT $53.61
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 63.04
  • AVNT 32.95
  • Support Level
  • AMRX $11.29
  • AVNT $28.87
  • Resistance Level
  • AMRX $12.12
  • AVNT $30.65
  • Average True Range (ATR)
  • AMRX 0.45
  • AVNT 1.12
  • MACD
  • AMRX 0.06
  • AVNT -0.14
  • Stochastic Oscillator
  • AMRX 77.70
  • AVNT 8.62

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About AVNT Avient Corporation

Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.

Share on Social Networks: